|
|
Article: Stakeholder Opinions - Celiac Disease - Licensing opportunities exist in untapped market.
- Article from:
- M2 Presswire
- Article date:
- May 7, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-7 May 2009-www.companiesandmarkets.com: Stakeholder Opinions - Celiac Disease - Licensing opportunities exist in untapped market(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:07052009
-www.companiesandmarkets.com adds new report: Stakeholder Opinions - Celiac Disease - Licensing opportunities exist in untapped market
Introduction
Low disease awareness, poor diagnosis rates, combined with a lack of pharmaceutical industry involvement, has kept celiac disease from the limelight. However, this is changing as evidenced by Shire's recent involvement in the pipeline. Datamonitor believes a drug for celiac disease is up to 5 years away ...